BIOGEN INC. (BIIB) Net margin 2016–2025
BIOGEN INC. (BIIB) net profit margin by fiscal year — reported net income divided by reported revenue.
13.1%FY2025 · since FY2016: 32.3% → 13.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 13.1% | -3.8 pp |
| FY2024 | 16.9% | +5.1 pp |
| FY2023 | 11.8% | -18.1 pp |
| FY2022 | 29.9% | +15.8 pp |
| FY2021 | 14.2% | -15.6 pp |
| FY2020 | 29.8% | -11.2 pp |
| FY2019 | 41.0% | +8.0 pp |
| FY2018 | 32.9% | +12.2 pp |
| FY2017 | 20.7% | -11.7 pp |
| FY2016 | 32.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More BIIB financial trends
BIIB RevenueBIIB Net incomeBIIB Gross profitBIIB Gross marginBIIB Operating incomeBIIB Operating marginBIIB Operating cash flowBIIB Free cash flowBIIB Capital expendituresBIIB Return on equityBIIB Stock buybacksBIIB Dividends paidBIIB Total assetsBIIB Total liabilitiesBIIB Shareholders’ equityBIIB overview →